HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

Shenzhiling

used to treat the diseases, such as insomnia, amnesia, emotional disorders

Networked: 5 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        Shenzhiling: 5
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - Shenzhiling: 5

Experts

1.	Huang, Shuaiyang: 4 articles (10/2021 - 01/2019)
2.	Wang, Pengwen: 4 articles (10/2021 - 01/2019)
3.	Liu, Zhenhong: 3 articles (10/2021 - 01/2019)
4.	Mana, Lulu: 3 articles (10/2021 - 01/2020)
5.	Wang, Yahan: 3 articles (07/2021 - 01/2019)
6.	Qin, Gaofeng: 2 articles (10/2021 - 07/2021)
7.	Chen, Fang: 2 articles (01/2020 - 01/2019)
8.	Chen, Chao: 1 article (12/2021)
9.	Hu, Yuan: 1 article (12/2021)
10.	Liu, Ping: 1 article (12/2021)

Related Diseases

1.	Cognitive Dysfunction 01/01/2019 - "As a traditional Chinese medicine compound preparation, the mechanism by which Shenzhiling (SZL) oral liquid can alleviate the cognitive impairment of SAD by improving synaptic plasticity remains unclear. " 07/01/2021 - "Moreover, results of electron microscopy, western blot, and polymerase chain reaction showed that Shenzhiling oral solution improved early cognitive impairment and repaired myelin sheath damage; the potential mechanism of these effects may relate to the PI3K/Akt-mTOR signaling pathway. "
2.	Depressive Disorder (Melancholia) 12/05/2021 - "This very first study evaluated the efficacy and tolerability of ShenZhiLing (SZL) tablets (KXS preparation), compared with fluoxetine (FLX, positive comparator), in patients with mild to moderate depressive disorder. "
3.	Alzheimer Disease (Alzheimer's Disease) 10/05/2021 - "Shenzhiling oral liquid protects the myelin sheath against Alzheimer's disease through the PI3K/Akt-mTOR pathway." 10/05/2021 - "Shenzhiling oral liquid (SZL), a traditional Chinese medicine (TCM) compound, is firstly approved by the Chinese Food and Drug Administration (CFDA) for the treatment of mild to moderate Alzheimer's disease (AD). " 01/01/2020 - "Shenzhiling oral liquid (SZL) is a Traditional Chinese Medicine (TCM) compound to be approved by the China Food and Drug Administration (CFDA) (Z20120010) for the treatment of mild-to-moderate Alzheimer's disease (AD). " 07/01/2021 - "These findings support the application and promotion of Shenzhiling oral solution to treat sporadic Alzheimer's disease. "

Related Drugs and Biologics

1.	Solutions
2.	Tablets
3.	Fluoxetine (Prozac)

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)